FRI0636 ENDOTHELIAL DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS -A CASE-CONTROL STUDY AND AN UPDATED META-ANALYSIS AND META-REGRESSION
Background: Endothelium-dependent flow-mediated dilation (ED-FMD), a biophysical marker of endothelial dysfunction, is apparently impaired in patients with systemic lupus erythematosus (SLE). However, such observation is inconsistent because of the lack of standardization of the methodology of ED-FMD measurement and inclusion of patients with different comorbidities amongst different studies. Objectives: Firstly, we evaluated if ED-FMD is indeed impaired in SLE patients naïve of cardiovascular disease and its traditional risk factors. Secondly, we aimed to determine if the putative contribution of SLE to endothelial dysfunction is in fact confounded by demographic-, disease-and treatment-related factors. Methods: We assessed and compared the brachial artery ED-FMD (baED-FMD) using the Prosound Alpha-10 ultrasound system ® between SLE patients without cardiovascular disease and cardiovascular risk factors and healthy controls (HC) matched for age, gender and body mass index (BMI). Exclusions were pregnancy, a history hypertension, diabetes mellitus, chronic kidney disease, cardiovascular and cerebrovascular diseases, and statin therapy. SLE-related disease activity and organ damage in the SLE patients were assessed using SELENA-SLEDAI and SLICC/ACR DI, respectively. With inclusion of our own data from this case-control study, we performed a comprehensive meta-analysis of case-control studies which compared baED-FMD between SLE patients and HC by determining the effect size of baED-FMD as standard mean difference (SMD). Demographic and clinical factors associated with the effect size were explored by mixed-model meta-regression. Results: Seventy one SLE patients and 71 HC were studied, and there were 6 men in each group. The mean±SD age and BMI of SLE patients and HC were 39.21±13.4 and 40.37±12.9 years, and 22.54±5.1 and 22.86±4.2 kg/m 2 , respectively. In SLE patients, the mean±SD daily prednisolone dose, SELENA-SLEDAI and SLICC/ACR DI were 13.43±14.4mg, 6.52±5.4 and 0.17±0.4, respectively. SLE patients had significantly lower baED-FMD than HC (3.72±2.8% vs 4.63±3.1%, p=0.032). In the SLE group, no association between baED-FMD and age, gender, BMI, blood pressure, duration of SLE, serum C3, C4 and antidsDNA levels, SELENA-SLEDAI, SLICC/ACR DI and daily prednisolone dose was found. Similarly, no association was noted between baED-FMD and age, gender and BMI in the HC group. Meta-analysis of 25 case-control studies involving 1,313 SLE patients and 1,012 HC with the random effects model revealed significantly lower baED-FMD in SLE patients compared to HC (SMD -1.077, p<0.001) (see Fig for forest plot) . The presence of diabetes mellitus (p=0.04747), higher diastolic blood pressure (p=0.04419) and renal involvement (p=0.02721) were associated with more discrepant baED-FMD between both groups. Background: Ultrasonography (US) has demonstrated to be an accurate tool for the diagnosis of calcium pyrophosphate deposition disease (CPPD) (1). Recently, the OMERACT "US in CPPD" subtask force, has created new definitions for CPPD identification by US, that demonstrated to be reliable at the knee joint, bridging a gap afflicting the old definitions (2). On the other hand, synovial fluid analysis (SFA) is considered to be an accurate and valid method for diagnosing CPPD. Objectives: The aim of this study wasto evaluate the association between US, using for the first time the new OMERACT US criteria for CPPD, and SFA findings for identifying patients affected by CPPD. Methods: We enrolled all the consecutive patients, aged more than 60 years old, referred to our outpatient clinic from September 2016 to December 2016, for knee pain and that presented knee effusion of any grade. Patients with suspected chronic inflammatory conditions were excluded. All the subjects underwent an US exam (EsaoteMyLab 70) of the clinically involved knee, performed by an expert sonographer that applied the new OMERACT criteria for the diagnosis of CPPD at the fibrocartilage (menisci) and hyaline cartilage of the affected knee (2). Subsequently, a US-guided arthrocentesis was performed, and the synovial fluid was collected and analyzed by a compensated polarized light microscopy (AxioLab A.1 [Zeiss] ) by an expert observer in order to assess the presence of CPP crystals. Both observers were blinded to clinical and to each other findings. The Chi-squared test was used to correlate the US and SFA findings. Results: 49 patients (28 women) were enrolled in the study, with a mean age of 70,29yo (SD±10,93). 28 subjects were affected by CPPD at SFA and 26 patients were identified as affected by CPPD at US. In 4 patients, the SFA was positive and the US was negative, while in 2 patients the SFA was negative and the US positive. Using the chi-squared test, a very strong association was found between the exams, with a p-value <0,0001.
Conclusions

Conclusions:
The new OMERACT US criteria for CPPD identification have already demonstrated to be reliable, considering the good to high kappa values yielded in previous multi-observer studies (2). This preliminary study, indicates that the new criteria seem to be also accurate for diagnostic purposes as they strongly correlate with the SFA for the presence of CPPD in knee joints. Further validation studies that will be able to assess the diagnostic accuracy of US are already in the research agenda of the OMERACT group "US in CPPD". Background: Disorders of the long head of the biceps brachii tendon (LHBt) are commonly recognized as a source of shoulder pain. Ultrasound (US) is thought to be of limited value in the diagnosis of partial-thickness tear and non-tear abnormalities of the LHBt because of the difficulty to assess its intraarticular proximal portion. Brasseur recently described that placing the arm in extension/external rotation increased LHBt intra-articular portion visibility. Objectives: The goal of this study was to determine if the systematic assessment of the intra-articular portion of the tendon, from the rotator interval to its glenoid insertion, with the arm placed in extension/external rotation could increase US sensitivity. Methods: This was a cross-sectional study. All patients referred for the treatment of a rotator cuff disease (rupture, tendinopathy, calcific deposit) with an available MRI were included. US was performed blinded from the results of the clinical or MRI using a Sonosite Edge with a 6-13 MHz probe. LHBt was studied at different level: in the bicipital groove, at the rotator interval, over the upper pole of the humerus head to its insertion on the superior glenoid tubercule. To increase the visibility of the proximal portion, we placed the arm in extension/external rotation as described by Brasseur [1] . Diagnosis of tendinopathy were tendon enlargement, hypoechogenicity and an increase in the interfibrillar distance. Subluxation or dislocation of the LHBt was defined as a partial or total loss of contact between the tendon and its groove. Tearing of tendon was defined as discontinuity or absence of tendon fibers. Fluid collection was defined as an anechoic ring around the tendon >2 mm. Abnormalities of the LBHt on MRI was retrieved from the report. LBHt abnormalities detected on arthroscopy were used as the gold standard. Results: We included 129 patients, 57 female (44%), and mean age 54 years (33-73). Seventy-five (58%) had a rotator cuff tear and 54 (42%) a tendinopathy. Arthroscopy found LHBt pathological changes in 39% of the case. The summary of the findings obtained with MRI, US (distal and proximal) and arthroscopy are summarised in table 1. We calculated the sensitivity/specificity of MRI and US (at the proximal and distal level) in the detection of LHBt changes using arthroscopy as gold standard (Table  2) . Conclusions: US has a good specificity but a poor sensitivity in the detection of LHB tendon changes even when a systematic and carreful study of the proximal part of the tendon is undertaken. If detection of distal changes of the tendon in the inter-tubercular groove seems feasible with US, the involvement of the more proximal, intra-articular part of the tendon remains challenging. MRI sensitivity remains also poor. Overall, arthroscopy still remains the gold standard to detect LHB tendon intra-articular pathology.
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